La inversión en salud como prioridad para América Latina y el Caribe

1. Valentina Sader: Health Investment as a Strategic Driver

Timestamp: 00:09:03 to 00:10:52 - watch this moment on skim

Investing in health systems is a regional priority that requires considering the macroeconomic effects of a healthy population. For growth and investment attraction, a healthy workforce and sustainable health systems are essential, especially in a context of fiscal constraints.

Significance (High): This frames health not just as a social good but as a fundamental economic engine. It sets the stage for discussions on how health policy directly influences national productivity and competitiveness.

Sources in support: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center), Patrick Actor (Regional Director for Latin America, R-Farma), Ana María Vesga (Minister of Health of Colombia), Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO)), Janet Ji (Executive Director, FIFARMA)

2. Patrick Actor: The Economic Case for Health Spending

Timestamp: 00:12:03 to 00:13:53 - watch this moment on skim

Investing in health goes beyond treating illness; timely diagnosis and effective treatment enable people to work, study, and contribute to their communities. The socioeconomic burden of seven diseases in eight Latin American countries represented nearly 4% of GDP, highlighting the economic cost of inaction.

Significance (High): This point quantifies the economic impact of poor health, directly linking health outcomes to GDP. It provides a compelling argument for increased health spending by framing it as an investment with tangible financial returns.

Sources in support: Patrick Actor (Regional Director for Latin America, R-Farma), Ana María Vesga (Minister of Health of Colombia), Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO)), Janet Ji (Executive Director, FIFARMA)

Neutral sources: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center)

3. Ana María Vesga: Prioritizing Immunization and Data

Timestamp: 00:14:47 to 00:18:17 - watch this moment on skim

In Colombia's constrained fiscal environment, priority investments in health include immunization strategies across the lifespan due to their cost-effectiveness. Additionally, strengthening data collection and measurement systems is crucial to demonstrate the return on investment in health to finance ministries.

Significance (High): This highlights practical, evidence-based strategies for resource allocation in health. By focusing on cost-effective interventions and robust data, the minister aims to bridge the gap between health needs and fiscal realities.

Sources in support: Ana María Vesga (Minister of Health of Colombia), Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO))

Neutral sources: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center), Patrick Actor (Regional Director for Latin America, R-Farma), Janet Ji (Executive Director, FIFARMA)

4. Jarbas Barbosa: The Cost of Inaction and Strategic Investments

Timestamp: 00:18:50 to 00:23:14 - watch this moment on skim

The pandemic proved that economic function depends on health function. Key investments should focus on prevention and primary care, managing non-communicable diseases like hypertension (where control rates are low), and leveraging digital transformation for better access and quality, especially in remote areas.

Significance (High): Barbosa emphasizes the critical link between health and economic stability, using the pandemic as a stark example. His focus on NCDs and digital health points to high-impact areas for investment that yield social and economic returns.

Sources in support: Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO)), Ana María Vesga (Minister of Health of Colombia), Janet Ji (Executive Director, FIFARMA)

Neutral sources: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center), Patrick Actor (Regional Director for Latin America, R-Farma)

5. Janet Ji: Innovation as an Investment, Not Just Expenditure

Timestamp: 00:23:36 to 00:27:41 - watch this moment on skim

Innovation in health, while intangible, is a crucial investment that generates long-term well-being and economic benefits. The significant delay (5.7 years) in bringing innovations to Latin American patients highlights a critical challenge that needs addressing to ensure value and progress.

Significance (High): Ji argues that innovation, often perceived as a cost, should be viewed as a strategic investment with long-term payoffs. The statistic on delayed access underscores the urgency for systemic improvements.

Sources in support: Janet Ji (Executive Director, FIFARMA), Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO))

Neutral sources: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center), Patrick Actor (Regional Director for Latin America, R-Farma), Ana María Vesga (Minister of Health of Colombia)

6. Ana María Vesga: Enhancing Efficiency in Colombian Healthcare

Timestamp: 00:28:30 to 00:32:18 - watch this moment on skim

Colombia faces efficiency challenges in healthcare spending, particularly in stabilizing resource flows between agents and improving contracting models beyond fee-for-service. Direct government negotiation for high-cost medicines and training providers in value-based contracting are key strategies.

Significance (High): This point addresses the practical, systemic issues within Colombia's health sector, focusing on efficiency gains through better negotiation, contracting, and provider training to manage costs without sacrificing innovation.

Sources in support: Ana María Vesga (Minister of Health of Colombia), Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO))

Neutral sources: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center), Patrick Actor (Regional Director for Latin America, R-Farma), Janet Ji (Executive Director, FIFARMA)

7. Jarbas Barbosa: Public Spending and Efficient Allocation

Timestamp: 00:33:22 to 00:36:29 - watch this moment on skim

Increasing public health spending is vital, but efficiency is paramount. PAHO advocates for evidence-based advocacy to demonstrate how targeted investments, like strengthening primary care, can reduce out-of-pocket expenses, improve access, and yield significant returns, rather than just increasing overall expenditure.

Significance (High): Barbosa counters the notion that more spending automatically equals better outcomes, emphasizing the need for strategic, efficient allocation of public funds. This perspective is crucial for convincing finance ministries and ensuring public resources are used effectively.

Sources in support: Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO)), Ana María Vesga (Minister of Health of Colombia)

Neutral sources: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center), Patrick Actor (Regional Director for Latin America, R-Farma), Janet Ji (Executive Director, FIFARMA)

8. The Evolving Role of Primary Care

Timestamp: 00:36:31 to 00:37:13 - watch this moment on skim

Primary healthcare in Latin America must evolve beyond maternal and child health to effectively manage chronic conditions like hypertension and diabetes, address mental health, and reduce adolescent pregnancies. An outdated primary care system fails to meet current needs and integrate with specialized networks, diminishing its overall effectiveness.

Significance (High): This highlights the critical need for modernizing primary healthcare systems to tackle the complex health challenges of today, ensuring better patient outcomes and system efficiency.

Sources in support: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center)

9. Access to New Technologies and Cost Savings

Timestamp: 00:37:16 to 00:38:24 - watch this moment on skim

Latin American countries, through collective purchasing mechanisms, gain faster access to new health technologies like HPV and PCV vaccines, significantly reducing childhood hospitalizations and mortality. This approach also achieves substantial cost savings (50-70%) on high-cost medications for conditions like cancer and multiple sclerosis compared to individual country purchases.

Significance (High): This demonstrates how strategic, region-wide procurement can democratize access to life-saving innovations and dramatically lower healthcare costs, making advanced treatments more attainable.

Sources in support: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center)

10. Justifying Innovation in Health Budgets

Timestamp: 00:39:29 to 00:40:57 - watch this moment on skim

Defending innovation in health budgets requires robust data to demonstrate the long-term economic benefits of reduced complications, hospitalizations, and disabilities. Persistent, consistent dialogue and a long-term perspective (5-20 years) are essential to convince resource allocators that health investments are critical for development, not just short-term costs.

Significance (High): This underscores the need for a paradigm shift in how health investments are viewed – from expenditure to a fundamental driver of economic growth and societal well-being.

Sources in support: Patrick Actor (Regional Director for Latin America, R-Farma)

11. The Challenge of Insufficient Health Investment

Timestamp: 00:42:58 to 00:44:42 - watch this moment on skim

Latin America faces a dual challenge: investing more in health, as most countries fall short of the recommended 6% of GDP, and significantly increasing efficiency due to rapidly growing health needs driven by an aging population. This necessitates a strategic approach to both funding and resource allocation.

Significance (High): This sets the stage for the panel's discussion, highlighting the urgent need for practical solutions to enhance both the quantity and quality of health spending in the region.

Sources in support: Ana María Vesga (Minister of Health of Colombia)

12. Argentina's Approach to Sustainable Health Investment

Timestamp: 00:45:08 to 00:47:58 - watch this moment on skim

Argentina prioritizes immunization and is adapting legal/administrative structures to attract investment, focusing on long-term demographic and health data to guide policy beyond short-term political cycles. This involves developing new administrative structures and leveraging demographic reports for strategic planning.

Significance (Medium): This approach aims to create a more stable and evidence-based framework for health investment, ensuring continuity and impact across different administrations.

Sources in support: Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO))

13. Panama's Strategy: Investment as Savings

Timestamp: 00:49:32 to 00:53:25 - watch this moment on skim

Panama advocates for viewing health spending as an investment that yields long-term savings by reducing chronic disease burdens, improving workforce productivity, and enhancing economic resilience. Key strategies include leveraging collective purchasing for medications, investing in technology like telemedicine, and implementing innovative procurement methods such as 'reverse auctions'.

Significance (High): This perspective reframes health expenditure, making a compelling case for increased funding by demonstrating its direct contribution to economic prosperity and societal well-being.

Sources in support: Janet Ji (Executive Director, FIFARMA)

14. Collaborative Procurement and Efficiency in Argentina

Timestamp: 00:57:51 to 01:00:57 - watch this moment on skim

Argentina's Ministry of Health acts as a rector, facilitating joint procurement among provinces to achieve better prices and efficiency, addressing the issue of different agencies buying the same product at varying costs. This strategy, along with risk-sharing agreements with pharmaceutical companies, aims to optimize resource utilization and establish national price benchmarks.

Significance (Medium): This centralized approach to procurement and negotiation is crucial for controlling costs and ensuring equitable access to essential medicines across the nation.

Sources in support: Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO))

15. Panama's Push for Public-Private Partnerships

Timestamp: 01:06:43 to 01:07:23 - watch this moment on skim

Panama is actively promoting public-private partnerships (PPPs) to drive investment and development, particularly aiming to establish a pharmaceutical hub. By modifying laws and engaging with industry associations, the country seeks to enhance its logistical capabilities and attract investment in the pharmaceutical sector.

Significance (Medium): These initiatives signal Panama's strategic intent to leverage private sector expertise and capital to bolster its healthcare infrastructure and economic potential.

Sources in support: Janet Ji (Executive Director, FIFARMA)

16. Streamlining Drug Registration

Timestamp: 01:07:25 to 01:08:45 - watch this moment on skim

Simplifying and expediting the registration process for new medications and medical devices is crucial for attracting investment and ensuring timely access to essential treatments. Previously, this process could take months or years, but recent reforms have reduced it to as little as 20 days, significantly boosting operational efficiency for commercial houses and encouraging further investment in the country.

Significance (High): This reform directly addresses a major bottleneck in healthcare access, potentially leading to quicker availability of innovative treatments and a more dynamic market for pharmaceutical companies.

Sources in support: Valentina Sader (Director of Strategy and Programs, Atlantic Council's Adrienne Arsht Latin America Center)

Neutral sources: Patrick Actor (Regional Director for Latin America, R-Farma)

17. Joint Procurement for Savings

Timestamp: 01:08:51 to 01:09:40 - watch this moment on skim

Implementing joint procurement strategies between entities like the Social Security and the Ministry of Health significantly reduces costs and optimizes resource allocation. By consolidating purchasing power, the state can achieve substantial savings, as demonstrated by the homologation of basic drug lists and the move towards a single, unified purchasing process for both institutions.

Significance (High): This consolidation of purchasing power is a strategic move to maximize budget efficiency, directly translating into more resources available for patient care and public health initiatives.

Sources in support: Patrick Actor (Regional Director for Latin America, R-Farma)

Neutral sources: Janet Ji (Executive Director, FIFARMA)

18. Data-Driven Decision Making

Timestamp: 01:12:16 to 01:13:58 - watch this moment on skim

Integrating disparate data sources and transforming raw data into actionable information is fundamental for effective decision-making in healthcare. By ensuring different departments and systems communicate and share data, organizations can gain insights into patient populations, track key metrics, and identify areas for improvement, thereby enhancing strategic planning and operational efficiency.

Significance (High): This emphasizes the foundational role of data analytics in modern healthcare, enabling proactive problem-solving and evidence-based policy adjustments.

Sources in support: Ana María Vesga (Minister of Health of Colombia)

Neutral sources: Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO))

19. Digital Health and AI in Panama

Timestamp: 01:16:14 to 01:18:08 - watch this moment on skim

Panama is making significant investments in digital health technologies, including artificial intelligence and integrated electronic health records, to overcome systemic challenges like non-communicating systems. The goal is to create a unified patient experience, from prescription management to telemedicine, ensuring better access and more informed care, even if AI is seen as a tool rather than a complete solution.

Significance (High): This strategic embrace of digital transformation signals a commitment to modernizing healthcare infrastructure and leveraging technology to address long-standing access and efficiency issues.

Sources in support: Jarbas Barbosa da Silva Jr. (Director of the Pan American Health Organization (PAHO))

Neutral sources: Janet Ji (Executive Director, FIFARMA)

Pharmaceutical Industry Influence (Medium severity)

Type: Commercial

Representatives from the pharmaceutical industry (Fifarma, R-Farma) are actively participating and advocating for increased health investment, framing it as an economic imperative. Their financial interests lie in the sale of pharmaceuticals and healthcare products.

Significance: This commercial tie raises questions about whether the emphasis on specific investment types, particularly those benefiting the pharmaceutical sector, is driven by public health needs or industry profit motives. The audience must consider if the proposed solutions adequately balance patient well-being with commercial interests.